Trump का 200% Tariff! Indian Pharma Stocks पर बड़ा खतरा? Sun Pharma, Cipla, Dr Reddy's Analysis

US President Donald Trump has announced a phased tariff plan on generic drugs that could significantly impact Indian pharmaceutical companies. In this video, we explain the complete timeline of the proposed tariffs, why Indian pharma stocks fell, which companies face the highest risk, and what investors should watch going forward.